Matches in Wikidata for { <http://www.wikidata.org/entity/Q34367199> ?p ?o ?g. }
- Q34367199 description "2004 nî lūn-bûn" @default.
- Q34367199 description "2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած" @default.
- Q34367199 description "2004 թվականի նոյեմբերին հրատարակված գիտական հոդված" @default.
- Q34367199 description "2004年の論文" @default.
- Q34367199 description "2004年論文" @default.
- Q34367199 description "2004年論文" @default.
- Q34367199 description "2004年論文" @default.
- Q34367199 description "2004年論文" @default.
- Q34367199 description "2004年論文" @default.
- Q34367199 description "2004年论文" @default.
- Q34367199 description "2004年论文" @default.
- Q34367199 description "2004年论文" @default.
- Q34367199 description "2004年论文" @default.
- Q34367199 description "2004年论文" @default.
- Q34367199 description "2004年论文" @default.
- Q34367199 description "2004년 논문" @default.
- Q34367199 description "article científic" @default.
- Q34367199 description "article scientific" @default.
- Q34367199 description "article scientifique (publié 2004)" @default.
- Q34367199 description "articol științific" @default.
- Q34367199 description "articolo scientifico" @default.
- Q34367199 description "artigo científico (publicado na 2004)" @default.
- Q34367199 description "artigo científico (publicado na 2004)" @default.
- Q34367199 description "artigo científico" @default.
- Q34367199 description "artikull shkencor" @default.
- Q34367199 description "artikulong pang-agham" @default.
- Q34367199 description "artykuł naukowy" @default.
- Q34367199 description "artículo científico publicado en 2004" @default.
- Q34367199 description "artículu científicu espublizáu en 2004" @default.
- Q34367199 description "bilimsel makale" @default.
- Q34367199 description "bài báo khoa học" @default.
- Q34367199 description "mokslinis straipsnis" @default.
- Q34367199 description "naučni članak" @default.
- Q34367199 description "scienca artikolo" @default.
- Q34367199 description "scientific article" @default.
- Q34367199 description "teaduslik artikkel" @default.
- Q34367199 description "tieteellinen artikkeli" @default.
- Q34367199 description "tudományos cikk" @default.
- Q34367199 description "vedecký článok" @default.
- Q34367199 description "vetenskaplig artikel" @default.
- Q34367199 description "videnskabelig artikel (udgivet 2004)" @default.
- Q34367199 description "vitenskapelig artikkel" @default.
- Q34367199 description "vitskapeleg artikkel" @default.
- Q34367199 description "vědecký článek" @default.
- Q34367199 description "wetenschappelijk artikel" @default.
- Q34367199 description "wissenschaftlicher Artikel" @default.
- Q34367199 description "επιστημονικό άρθρο" @default.
- Q34367199 description "мақолаи илмӣ" @default.
- Q34367199 description "мақолаи илмӣ" @default.
- Q34367199 description "наукова стаття, опублікована в листопаді 2004" @default.
- Q34367199 description "научна статия" @default.
- Q34367199 description "научная статья" @default.
- Q34367199 description "научни чланак" @default.
- Q34367199 description "научни чланак" @default.
- Q34367199 description "מאמר מדעי" @default.
- Q34367199 description "سائنسی مضمون" @default.
- Q34367199 description "مقالة علمية" @default.
- Q34367199 description "مقالهٔ علمی" @default.
- Q34367199 description "২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34367199 description "บทความทางวิทยาศาสตร์" @default.
- Q34367199 description "სამეცნიერო სტატია" @default.
- Q34367199 name "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 name "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 name "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 type Item @default.
- Q34367199 label "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 label "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 label "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 prefLabel "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 prefLabel "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 prefLabel "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 P1433 Q34367199-CBD0646D-E2BD-4857-9C31-A93FC184CB12 @default.
- Q34367199 P1476 Q34367199-26376FF4-9EED-409E-A00C-F3D6A4CEFB75 @default.
- Q34367199 P2093 Q34367199-08BE4C9B-5CD5-4CC9-8ECD-B266CE251406 @default.
- Q34367199 P2093 Q34367199-4DD9909B-C9EF-4B2A-943D-EAB6BFDF4CCB @default.
- Q34367199 P2093 Q34367199-628CD3B0-5C95-4768-A959-C4B8E38E1B8C @default.
- Q34367199 P2093 Q34367199-7F69F0EA-2417-42B0-9BB3-88314FE0DF35 @default.
- Q34367199 P2093 Q34367199-880F3FF3-156A-4911-8597-9C0B417BD61C @default.
- Q34367199 P2093 Q34367199-8E40CFF1-B65E-4DFC-87B5-BD115F479D1A @default.
- Q34367199 P2093 Q34367199-9E7FD149-1CA7-4EBA-BFD1-B3A1D86A2D47 @default.
- Q34367199 P2093 Q34367199-A867BAC2-9128-40FB-9ED7-B5ECBB523D8E @default.
- Q34367199 P2093 Q34367199-BC3762F5-FD15-4A3D-B872-D680F2B40369 @default.
- Q34367199 P2093 Q34367199-DC0A5AA8-FD78-4C7A-B7A9-2AFD9A85AA55 @default.
- Q34367199 P2093 Q34367199-E89A6533-4D6F-418F-AB95-B9649F447EA7 @default.
- Q34367199 P304 Q34367199-CEAE721C-3E68-4E2E-BDB2-C1AA853C4EED @default.
- Q34367199 P31 Q34367199-1DE0E6D5-27C8-46AF-AD4B-12DEDDF640C3 @default.
- Q34367199 P356 Q34367199-BB4825A0-AE9D-4D82-A99E-6229CA0ED856 @default.
- Q34367199 P407 Q34367199-631EFC0F-680C-4D5E-9480-0614AABC5E3A @default.
- Q34367199 P433 Q34367199-B33F4DEC-6FE4-499C-A64D-75EC3B96484E @default.
- Q34367199 P478 Q34367199-A3772FDB-4151-46D7-9F35-87A17A2C8144 @default.
- Q34367199 P577 Q34367199-F1EF0D41-A435-4D59-8A1B-9AA82C243469 @default.
- Q34367199 P698 Q34367199-BA3B743B-A80F-45A4-B4EF-04AD9528472F @default.
- Q34367199 P921 Q34367199-9C51C1AC-1785-4F93-AA59-FFED4613CB78 @default.
- Q34367199 P921 Q34367199-BA128E75-B7E7-4FDC-96AE-F7D8A54672C8 @default.
- Q34367199 P921 Q34367199-D61938CD-3EE6-4986-A5A6-F294D52BD84B @default.
- Q34367199 P356 01.JU.0000139719.99825.54 @default.
- Q34367199 P698 15540741 @default.
- Q34367199 P1433 Q15709979 @default.
- Q34367199 P1476 "Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6." @default.
- Q34367199 P2093 "Ilker Tasdemir" @default.